Background
==========

Carcinoid tumors are neuroendocrine origin neoplasm and may produce serotonin or other functional peptide hormones. They are well-differentiated and low-grade malignant neoplasms. Approximately 74% of all carcinoid tumors arise from the gastrointestinal (GI) tract and the liver is a common site for metastases \[[@B1]\]. However, primary hepatic carcinoid tumor (PHCT) is very rare and the first case was documented by Edmondson in 1958 \[[@B2]\]. This rarity makes it difficult for clinicians to diagnose accurately before biopsy, resection of tumor, or autopsy \[[@B3]\]. Large-sized tumors are common presentations when they are diagnosed \[[@B4]\]. PHCT presents as a small and single nodule, is extremely rare and is difficult to differentiate from hepatocellular carcinoma (HCC), particularly in a region with high prevalence of HCC. Herein, we report a rare case of small PHCT with underlying HBV infection which was suspected to be a small HCC before operation and also comprehensively review 94 cases of PHCT in the literature.

Case presentation
=================

A 48-year-old Chinese female with HBV infection for 15 years was regularly followed up at gastroenterology outpatient department by abdominal ultrasound (US) and serum alpha-fetoprotein (AFP) screening every six months. In May 2005, abdominal US demonstrated a low echoic nodule, 1.6 × 1.6 cm in size in the sixth segment of the liver and mild parenchymal liver disease (Fig. [1A](#F1){ref-type="fig"}). She was asymptomatic and no abnormality was disclosed by physical examination. Noncontrast liver computed tomography (CT) showed a 1.6 × 1.6 cm well-circumscribed and low density nodule in the same liver segment (Fig. [1B](#F1){ref-type="fig"}). Dynamic CT scans showed enhancement of the nodule in the arterial phase and early washout in the portal phase (Figs. [1C](#F1){ref-type="fig"} and [1D](#F1){ref-type="fig"}). Serum was positive for hepatitis B surface antigen (HBsAg), but negative for HBeAg. The serum anti-HCV was also negative. AFP and CEA were within normal range. Based on the imaging findings and underlying HBV infection, small HCC was highly suspected and a US-guided liver biopsy was performed for definite diagnosis. However, the pathological finding suggested a malignant neoplasm originating form neuroendocrine cells (Fig. [2A](#F2){ref-type="fig"}). The result of immunohistochemical (IHC) stain was positive for neuron-specific enolase (NSE), synaptophysin, and chromogranin A (Fig. [2B](#F2){ref-type="fig"}). The pre-operative 24-hour urine 5-hydroxyindoleacetic acid (5-HIAA) value was within normal limits. We undertook a more thorough investigation to rule out the possibility that the liver tumor was a metastatic carcinoid. This workup included upper and low GI endoscopy, a small bowel series, abdominal US, and chest and abdominal CT scans. All imaging findings were unremarkable. Partial hepatectomy was performed. Small bowel, appendix and large bowel were checked during operation and no tumor was found. No cirrhotic liver was noted. The surgery was performed successfully and the patient recovered well. The resected liver tissue contained a 1.6 × 1.6 × 1.5 cm circumscribed tumor (Fig. [3](#F3){ref-type="fig"}). Histological examination revealed the round or ovoid neoplastic cells arranged in insular pattern with a rosette formation. There was no tumor embolus in the vessels and the resection line was free from tumor invasion. The IHC stains were positive for chromogranin A, cytokeratin, NSE, and synaptophysin. The final diagnosis was PHCT. She was followed up regularly at our hospital and remained disease-free 3 years after operation.

![**(A) Abdominal ultrasound shows a low echoic nodule in the sixth segment of the liver (arrowheads)**. **(B)**Noncontrast CT scan shows a well-circumscribed, low density nodule (arrowheads). **(C)**Dynamic CT scan shows enhancement of the nodule in the arterial phase (arrowheads). **(D)**Dynamic CT scan shows enhancement in the portal phase (arrowheads).](1757-1626-2-90-1){#F1}

![**(A) The tumor was composed of round or ovoid cells arranged in insular pattern with a rosette formation (hematoxylin and eosin)**. **(B)**The tumor cells were positive for chromogranin A.](1757-1626-2-90-2){#F2}

![**The resected liver contained a 1.6 × 1.6 × 1.5 cm circumscribed tumor (arrowheads)**.](1757-1626-2-90-3){#F3}

Discussion
==========

The origin of PHCT remains unknown. The cells may originate from ectopic pancreatic or adrenal tissue found within the liver or from scattered neuroendocrine cells in the intrahepatic biliary epithelium \[[@B5]\]. Some were observed in animal studies such as those found in the rat liver \[[@B6]\]. The scarcity of such cells may explain the rarity of primary hepatic neuroendocrine tumors. It is also proposed that chronic inflammation in the biliary system may induce intestinal metaplasia that predisposes to the development of neuroendocrine tumor \[[@B5]\].

Including our case, we found 94 cases of PHCT (including primary hepatic neuroendocrine tumor) in the literature \[[@B1]-[@B5],[@B7]-[@B15]\] and their clinical characteristics are summarized in Table [1](#T1){ref-type="table"}. This type of tumor occurs mainly in middle age (mean age, 49.8 years) and is slightly more frequent in females (58.5%). The most common symptom among 84 cases was abdominal pain (37 cases, 44.0%). Eleven cases were asymptomatic (13.1%). The overall mortality rate was 25.5% (24/94) as shown in Table [2](#T2){ref-type="table"}.

###### 

Clinical characteristics and imaging findings of 94 cases of primary hepatic carcinoid tumor

  Characteristics                                            Number (%)
  ---------------------------------------------------------- -------------------
  Age (y)^a^                                                 49.8 ± 16.0
  Gender (M/F)                                               39/55 (41.5/58.5)
  Clinical manifestations                                    
   Asymptomatic                                              11/84 (13.1)
   Abdominal pain                                            37/84 (44.0)
   Carcinoid syndrome                                        14/84 (16.7)
    Diarrhea                                                 8/84 (9.5)
    Flushing                                                 4/84 (4.8)
    Cushing syndrome                                         2/84 (2.4)
   Abdominal mass                                            12/84 (14.3)
   Fatigue                                                   6/84 (7.1)
   Zollinger-Ellison syndrome                                5/84 (6.0)
   Dyspnea                                                   4/84 (4.8)
   Jaundice                                                  4/84 (4.8)
   Anemia                                                    2/84 (2.4)
   Body weight loss                                          2/84 (2.4)
   Hypoglycermia                                             1/84 (1.2)
   Leg edema                                                 1/84 (1.2)
  Imaging finings                                            
   Ultrasound                                                
    Solid tumor                                              32/39 (82.1)
    Solid tumor with cystic component                        7/39 (17.9)
    Hyperechoic pattern                                      12/14 (85.7)
    Hypoechoic pattern                                       2/14 (14.3)
   Computed tomography                                       
    Low density tumor in noncontrast                         37/50 (74.0)
    Low density tumor with cystic component in noncontrast   17/50 (34.0)
    Tumor enhancement                                        20/50 (40.0)
    Enhanced in arterial phase and washout in portal phase   13/50 (26.0)
   Magnetic resonance imaging                                
    Low intensity in T1 and high intensity in T2             17/21 (81.0)
   Angiography                                               
    Hypervascular tumor                                      23/27 (85.2)
    Avascular tumor                                          4/27 (14.8)

^**a**^Present as mean value ± standard derivation

###### 

Location of tumor, histology and prognosis of 94 cases of primary hepatic carcinoid tumor

  Characteristics                                       Number (%)
  ----------------------------------------------------- --------------
  Location                                              
   unilobar                                             72/94 (76.6)
    Left lobe                                           28/94 (29.8)
    Right lobe                                          44/94 (46.8)
   billobar                                             22/94 (23.4)
  Number                                                
   Single                                               59/94 (62.8)
   Multiple                                             35/94 (37.2)
  Tumor size                                            
   ≦ 3 cm                                               7/74 (9.5)
   \> 3 cm                                              67/74 (90.5)
  Histological stains                                   
   Grimelius                                            64/71 (90.1)
   Fontana-Masson stains                                14/34 (41.2)
  Immunohistochemical stains                            
   Chromogranin A                                       57/64 (89.1)
   Neuron specific enolase                              43/58 (74.1)
   Synaptophysin                                        23/47 (48.9)
   cytokeratin                                          22/40 (55.0)
  Misdiagnosed as HCC by microscopy before IHC stains   11/94 (11.7)
  Prognosis                                             
   Alive                                                70/94 (74.5)
   Death                                                24/94 (25.5)
  Treatment                                             
   Hepatectomy                                          73/84 (86.8)
   Liver transplantation                                3/84 (3.6)
   Transcatheter arterial embolization                  3/84 (3.6)
   Chemotherapy                                         2/84 (2.4)
   Radiotherapy                                         2/84 (2.4)
   Radiofrequency ablation                              1/84 (1.2)
  Recurrence                                            
   No recurrence                                        53/75 (70.7)
   Recurrence                                           22/75 (29.3)

HCC: Hepatocellular Carcinoma; IHC: Immunohistochemical;

The case we presented was a small and asymptomatic PHCT. In the literature, only 9.5% (7/74) and 13.1% (11/84) of cases were small-sized tumors (≦ 3 cm) and asymptomatic PHCTs, respectively. Their prognosis was good and the survival rate was 100 % for the 7 small-sized tumor cases and 90.1% (10/11) for the asymptomatic cases, only one of which died as a result of renal cell carcinoma.

The rarity of PHCT makes it difficult to diagnose accurately before biopsy or resection. In previous reports, 4 (4.3%) and 5 (5.3%) cases were diagnosed as HCC \[[@B8]-[@B10]\] and cholagiocarcinoma \[[@B11],[@B12]\] respectively by imaging and clinical findings before operation. Moreover, PHCT is also difficult to diagnose because of the histological similarity with HCC \[[@B3]\]. 11.7% (11/94) of cases were misdiagnosed as HCC by light microscopy until they revealed the features of carcinoid tumor by IHC examinations \[[@B3],[@B7],[@B9],[@B13]\]. Furthermore, 6 (6.4%) cases had chronic liver disease with HBV or HCV infection and 3 (3.2%) cases with HBV infection were misdiagnosed as HCC before IHC stains \[[@B9],[@B14],[@B15]\]. Our case had the underlying hepatitis B liver disease and typical imaging presentation of HCC in dynamic CT scans. AFP level may not rise due to small size of tumor. In addition, Taiwan is a region with high prevalence of HBV and HCC. Thus, small HCC was highly suspected before biopsy. Carcinoid tumor was confirmed by liver biopsy and we arranged serial pre-operative and intra-operative examination to investigate the original site of tumor because the liver is a common site for metastases of carcinoid tumors \[[@B1]\]. The accurate diagnosis of carcinoid tumor before operation is very important because it can alert clinicians to seek possible sites of metastasis, thereby avoiding unnecessary operation or a second operation if a metastatic lesion is found.

Conclusion
==========

A small and asymptomatic PHCT is extremely rare. PHCT should be one of the differential diagnoses in patients with small hepatic tumor, even in regions with high prevalence of HBV infection and HCC. Pre-operative biopsy is necessary to avoid misdiagnosis even when HCC is highly suspected clinically.
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